The range and clinical impact of cognitive impairment in French patients with ALS: A cross-sectional study of neuropsychological test performance

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 5, 2011, Pages 372-378

  Gordon, Paul H ^a   Delgadillo, Daniel ^a   Piquard, Ambre ^a,e   Bruneteau, Gaelle ^a   Pradat, Pierre François ^a   Salachas, François ^a   Payan, Christine ^b   Meininger, Vincent ^a,c   Lacomblez, Lucette ^a,b,c,d  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSERM   (France)

^e Île de France Ouest University Paris   (France)

Author keywords

Amyotrophic lateral sclerosis; Cognitive impairment; Dementia; Frontotemporal dementia; Neuro psychological tests; Neurodegeneration

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BULBAR PARALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MUSCLE WEAKNESS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SURVIVAL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SURVIVAL RATE;

EID: 80053932223     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.580847     Document Type: Article

References (35)

1. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130-3. (Pubitemid 44547757)
2. Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009;66:180-9.
3. Rippon GA, Scarmeas N, Gordon PH, Murphy PL, Albert SM, Mitsumoto H, et al. An observational study of cognitive impairment in ALS. Arch Neurol. 2006;63:345-52.
4. Raaphorst J, de Visser M, Linssen WH, De Haan RJ, Schmand B. The cognitive profi le of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph Lateral Scler. 2009; 29:1-13.
5. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586-90. (Pubitemid 41170719)
6. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094-7. (Pubitemid 36418766)
7. Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, et al. A prospective cohort study of neuropsychological test performance in ALS. Amyotroph Lateral Scler. 2010;11:312-20.
8. Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Later Scler. 2009;10:131-46.
9. Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
10. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13-21. (Pubitemid 29502501)
11. Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265-7. (Pubitemid 43970171)
12. Norris FH, U KS, Sachais B, Carey M. Trial of baclofen in amyotrophic lateral sclerosis. Arch Neurol. 1979;36:715-6. (Pubitemid 10226319)
13. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, et al. Screening for dementia with the memory impairment screen. Neurology. 1999;52;231-8. (Pubitemid 29059044)
14. Wechsler D. Wechsler Adult Intelligence Scale, 3rd edn. (WAIS-III). San Antonio TX, The Psychological Corporation.
15. Lezak MD. Neuropsychological assessment. 4. New York: Oxford University Press; 2004.
16. Deloche G, Hannequin D, Dordain M, Metz-Lutz MN, Kremin H, Tessier C, et al. Diversity of patterns of improvement in confrontation naming rehabilitation: some tentative hypotheses. J Commun Disord. 1997;30:11-21.
17. Golden CJ. Identifi cation of brain disorders by the Stroop Color and Word Test. J Clin Psychol. 1976;32:654-8.
18. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB, a frontal assessment battery at bedside. Neurology. 2000; 53:1621-6.
19. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson: Neuropsychology Press; 1985.
20. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y. Evocation Lexicale formelle et s é mantique chez des sujets normaux. Performances et dynamiques de production en fonction du sexe, de l ' â ge et du niveau d ' é tude. Acta Neurol Belg. 1990;90:207-17.
21. Psychological Assessment Resources. Computerized Wisconsin Card Sort Task Version 4 (WCST). Psychological Assessment Resources; 2003.
22. Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, et al. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology. 2005;64:1184-8.
23. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnosic criteria. Neurology. 1998;51:1546-54.
24. Marie P. Leç ons sur les maladies de la moelle. 1892. Paris Masson, Paris.
25. B raumü hl A von. Picksche Krankheit und amyotrophische Lateralsklerose. Allgemeine Z Psychiatr Psychol Med. 1932;96:364-6.
26. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57:416-8.
27. Mitsuyama Y. Presenile dementia with motor neuron disease. Dementia. 1993;4:137-42. (Pubitemid 23234423)
28. Wicks P, Turner MR, Abrahams S, Hammers A, Brooks DJ, Leigh PN, et al. Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-fl umazenil PET study. Amyotroph Lateral Scler. 2008; 9:43-9. (Pubitemid 351260372)
29. Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:530-4. (Pubitemid 46588341)
30. Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology. 1999;53:1665-70. (Pubitemid 29530337)
31. Cavalleri F, de Renzi E. Amyotrophic lateral sclerosis with dementia. Acta Neurol Scand. 1994;89:391-4. (Pubitemid 24163656)
32. Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, Graf M, Uttner I, Muche R, et al. Cognitive funtion in bulbar-and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol. 2005;252:772-81. (Pubitemid 40984851)
33. Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, et al. The effects of executive and behavioural dysfunction on the course of ALS. Neurology. 2005;65:1774-7.
34. Fritsch T, McClendon MJ, Smyth KA, Ogrocki PK. Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer ' s-type dementia. Int Psychogeriatr. 2002;14:347-63. (Pubitemid 36331602)
35. Wilson RS, Hebert LE, Scherr PA, Barnes LL, Mendes de Leon CF, Evans DA. Educational attainment and cognitive decline in old age. Neurology. 2009;72:460-5.